While Jade Biosciences Inc has underperformed by -0.65%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, JBIO fell by -5.16%, with highs and lows ranging from $13.50 to $5.06, whereas the simple moving average jumped by 3.98% in the last 200 days.
On June 16, 2025, Guggenheim Upgraded Jade Biosciences Inc (NASDAQ: JBIO) to Buy. A report published by Wedbush on May 07, 2025, Initiated its previous ‘Outperform’ rating for JBIO. Stifel also rated JBIO shares as ‘Buy’, setting a target price of $19 on the company’s shares in an initiating report dated May 05, 2025. TD Cowen Initiated an Buy rating on May 02, 2025, and assigned a price target of $10. Wells Fargo June 18, 2024d its ‘Overweight’ rating to ‘Equal Weight’ for JBIO, as published in its report on June 18, 2024. Evercore ISI also rated the stock as ‘In-line’.
Analysis of Jade Biosciences Inc (JBIO)
There are several well-rounded types of analysis and research techniques that can be used to gain a clear view of Jade Biosciences Inc’s future performance, with equity being one of the most critical indicators. The goal here is to ensure that your current return on equity of -59.01% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 32.01, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
As an indicator of volatility for any stock, average volume can also be very valuable, and JBIO is recording an average volume of 301.35K. On a monthly basis, the volatility of the stock is set at 11.53%, whereas on a weekly basis, it is put at 12.78%, with a loss of -7.08% over the past seven days. Furthermore, long-term investors anticipate a median target price of $16.67, showing growth from the present price of $9.19, which can serve as yet another indication of whether JBIO is worth investing in or should be passed over.
How Do You Analyze Jade Biosciences Inc Shares?
Apart from looking at the fundamentals, you should also pay attention to the number of company employees who own shares. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.20%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 34.74% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
JBIO shares are owned by institutional investors to the tune of 34.74% at present.
